Author

Abigail Twoy

Stanford MedicineORCID 0000-0001-5326-9108Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

Emily Soohoo· 3 shared Everett H. MeyeriD· 3 shared Kent P. JenseniD· 3 shared Avnesh Sinh ThakoriD· 2 shared Bettina Panagiota IliopoulouiD· 2 shared Biki GuptaiD· 2 shared Cameron S. BaderiD· 2 shared Mark M. DavisiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Emily Soohoo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyJournal of Clinical InvestigationPeer-reviewedOct 27, 2026

Donor-derived CD8+CD122+ Tregs generated in mixed donor chimeric NOD mice suppress autoreactive T cells

Shiva Pathak, Cameron S. Bader, Bettina Panagiota Iliopoulou…·Everett H. Meyer

This study identifies donor-derived CD8+CD122+ Tregs in mixed chimeric NOD mice that suppress autoreactive T cells and may offer a new therapeutic strategy for autoimmune diabetes.

DOI 10.1172/jci207024

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 3, 2026

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes

Shiva Pathak, Rizwan Ahmed, Nadine Nagy…·Everett H. Meyer

The paper identifies CD38 as a marker for pathogenic T cells in T1D and shows that anti-CD38 mAb selectively depletes these cells to prevent diabetes without affecting Tregs.

DOI 10.64898/2026.06.27.734105

mousehuman

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 2, 2026

Soluble LAG-3 Identifies a Dynamic Early T Cell Activation Window in self-reactivity, Type 1 Diabetes, and Broader Immune Responses.

Saptarshi Roy, Megan Lynn Proffer, Farooq Syed…·Jon D. Piganelli

This study identifies soluble LAG-3 (sLAG-3) as an early biomarker of T cell activation in type 1 diabetes, detectable before islet autoantibody development and associated with beta-cell stress and high-risk HLA genotypes.

1 citation

mousehuman

𝕏 PostBluesky